FIELD: pharmaceuticals.
SUBSTANCE: invention relates to (1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidine-3-yl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, a solvate or hydrate thereof, pharmaceutical compositions containing said compound, and to a method for treating a coronavirus infection such as COVID-19.
EFFECT: creation of new compounds for treating a coronavirus infection.
26 cl, 15 dwg, 41 tbl, 98 ex
Title | Year | Author | Number |
---|---|---|---|
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2820150C2 |
NEW AZABICYCLOHEXANE DERIVATIVES | 2023 |
|
RU2811800C1 |
SUBSTITUTED 3-AZABICYCLO[3_1_0]HEXANES AS KETOHEXOKINASE INHIBITORS | 2016 |
|
RU2696269C1 |
SYNTHESIS OF (1R,2S,5S)-N-[(1S)-1-CYANO-2-[(3S)-2-OXOPYRRROLIDIN-3-YL]ETHYL]-3-[(2S)-3,3-DIMETHYL-2-[(2,2,2-TRIFLUOROACETIL)AMINO]BUTANOIL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXAN-2-CARBOXAMIDE | 2022 |
|
RU2794748C1 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS | 2007 |
|
RU2448105C2 |
METHOD FOR PRODUCING (1R,2S,5S)-N-[(1S)-1-CYANO-2-[(3S)-2-OXOPYRRROLIDIN-3-YL]ETHYL]-3-[(2S)-3,3- DIMETHYL-2-[(2,2,2-TRIFLUORACETYL)AMINO]BUTANOYL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXAN-2-CARBOXAMIDE | 2022 |
|
RU2794754C1 |
CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF | 2012 |
|
RU2586885C2 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
Authors
Dates
2022-12-26—Published
2021-08-06—Filed